Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19 Continue reading
New CDC guidelines recommend widespread community maskingContinue reading
Due to the predicted dire ventilator shortage, Prisma Health received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the device in response to the urgency for more ventilators as a result of the pandemic.
Using 3D printing manufacturing technology, Ethicon will manufacture and distribute the VESper Ventilator Expansion Splitter at no cost to healthcare providers in the United States under the EUA during the current COVID-19 pandemic. The initial distribution of the device will be limited to the United States as Prisma Health and Ethicon are developing strategies to navigate various regulatory pathways and fulfill orders worldwide.
ASU’s Biodesign Institute will utilize Piper Trust support to increase its capacity for automated, rapid diagnostic testing to mitigate the viral spread and potential reoccurrence of COVID-19.
“Now is the time for those who can — individuals and public- and private-sector organizations — to step in quickly and support our nonprofits,” said Mary Jane Rynd, president and CEO of Virginia G. Piper Charitable Trust. “They are serving on the frontlines and are essential to our economic vitality.”
Starting April 1st, 2020 through July 1st, 2020, IMNA is offering free access to the TrialME platform for all teams researching COVID-19 and other life debilitating diseases.
TrialME offers sites a seamless shift to a hybrid structure that follows the FDA’s new guidelines during COVID-19 pandemic; the platform monitors, engages, and communicates with patients from the comfort and safety of their home. Continue reading
Amish Shah, MD is an emergency physician at Dignity Health and a member of the Arizona House of Representative elected by the people of LD24 – Central Phoenix and South Scottsdale. On Sunday, April 5, 2020, Dr. Shah shared the message below via Facebook. This Facebook post is republished with permission from Dr. Shah.Continue reading
The test helps fill an urgent need across the U.S. for hospitals to access an easy-to-use, rapid diagnostic test to screen patients and health care workers for COVID-19. The test will be run on the BD MAX™ System, a molecular diagnostic platform already in use at hundreds of laboratories in nearly every state across the country. Each unit is capable of analyzing hundreds of samples per day.Continue reading
- Adaptive Extends Immune Medicine Platform to Discover Therapeutic Antibodies From Recovered COVID-19 Patients
- Amgen Will Leverage Genetics, Immunology, Antibody Engineering and Manufacturing Capabilities
- Companies Will Begin Work Immediately
Point-of-care blood test detects evidence of present or past exposure in 15 minutesContinue reading